Dan Wolf

Dan Wolf is a managing director in the healthcare investment banking group based in the firm's Minneapolis office. Wold is focused on advising healthcare technology companies on mergers and acquisitions, strategic partnerships and capital raising transactions. He brings over 20 years of healthcare experience spanning investment banking, operating leadership and strategic advisory.

Previously, Wolf served as chief financial officer at Theradaptive, a clinical-stage protein engineering company. He also founded Convergence Bio Advisors, where he advised healthcare companies, boards and private equity firms on M&A transactions. Before that, Wolf was senior vice president and chief strategy officer at Baxter International, leading global strategic planning, portfolio management and corporate development activities. He previously spent 12 years at Medtronic in roles of increasing responsibility, including vice president and general manager of intelligent data solutions where he led the company's digital transformation and expansion into personalized spine surgery. Wolf began his career as a healthcare investment banking analyst at Piper Sandler.

Wolf received a bachelor’s degree in economics and mathematics from Bowdoin College. He also received a master's degree from the Massachusetts Institute of Technology and a Master of Business Administration degree from Harvard Business School.